AGC Biologics completes expansion of Italian cell and gene facility
As part of the expansion of the Milan site, AGC Biologics has added five suspension single-use bioreactors, including…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Aug 23
As part of the expansion of the Milan site, AGC Biologics has added five suspension single-use bioreactors, including…
10 Aug 23
Under the agreement, T-MAXIMUM Biotech will get several CRISPR reagents from GenScript to aid in the development of…
10 Aug 23
The proposed acquisition will enhance the ongoing partnership between Decibel and Regeneron and the partnership aims to expedite…
10 Aug 23
The capital garnered from the Series C financing will be channelled towards further advancement of ADARx's ongoing clinical…
09 Aug 23
Neopharm will be appointed as Amarin’s sole and exclusive distributor to import, register, distribute, and commercialise Vazkepa in…
09 Aug 23
The clinical trial comes after the company's Trial-Ready Screening Cohort Study conducted in 2022, which involved screening, enrolling,…
09 Aug 23
The goal of the collaboration is to identify small molecule candidates with activity towards a tumour suppressor protein…
09 Aug 23
FDA-approved generic for MRI procedures is fully substitutable for Gadavist
08 Aug 23
BioNTech will obtain rights to commercialise the DB-1305 worldwide, except in Mainland China, Hong Kong Special Administrative Region…
08 Aug 23
According to the terms of the agreement, Astellas will invest $25m to buy 8,333,333 shares of common stock…